The model also allowed the researchers to note features of this disease that are significant in humans, such as ring sideroblasts, a type of immature red blood cell. "The lack of ALAS2 in the ...

Moreover, while Reblozyl was only cleared for use as second-line therapy in MDS patients with ring sideroblasts – blood cells with a characteristic circle of iron deposits around their nucleus ...